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Objective: Helicobacter pylori (H. pylori) infection is the main cause of gastric inﬂammation. Regulatory T
cells (Treg cells) suppress the activation and proliferation of antigen-speciﬁc T cells and mediate
immunologic tolerance. TGF-b1 was shown to be secreted in a subset of Treg cells known as ‘Th3 cells’.
These cells have not been sufﬁciently studied in context to H. pylori-induced inﬂammation in human
gastric mucosa. In this study we therefore, aimed to investigate the expression of TGF-b1 in the context
of H. pylori colonization in chronic gastritis, to examine the relationship between it and histopathologic
ﬁndings and to compare it with virulence factors.
Patients and methods: Total RNA was extracted from gastric biopsies of 48 H. pylori-infected patients and
38 H. pylori-negative patients with gastritis. Mucosal TGF-b1 mRNA expression in H. pylori-infected and
uninfected gastric biopsies was determined by real-time PCR. Presence of vacA, cagA, iceA, babA2 and
oipA virulence factors was evaluated using PCR.
Results: TGF-b1 mRNA expression was signiﬁcantly increased in biopsies of H. pylori-infected patients
compared to H. pylori-uninfected patients. There was association between virulence factors and TGF-b1
mRNA expression. TGF-b1 mRNA expression in mucosa was signiﬁcantly higher in patients with vacA s1
and s1m1.
Conclusions: TGF-b1 may play an important role in the inﬂammatory response and promote the chronic
and persistent inﬂammatory changes in the gastric. This may ultimately inﬂuence the outcome of
H. pylori-associated diseases that arise within the context of gastritis and vacA may sufﬁce to induce
expression of TGF-b1 mRNA.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Colonization by H. pylori is known to cause chronic gastritis and
lead to the development of severe gastroduodenal diseases such as
peptic ulcers, lymphoma of the mucosa associated lymphoid tissue
(MALT) or gastric adenocarcinoma [1]. Activation and migration of
these inﬂammatory cells into the gastric mucosa is related to
increased production of pro-inﬂammatory cytokines, including
IFN-g, TNF-a, IL-1b, IL-18, IL-17, IL-8, IL-6 and various cytokinesx: þ98 3813330709.
irzad), n.bagheri1985@gmail.
All rights reserved.which are believed to contribute to maintaining the gastric
inﬂammation and causing epithelial cell damage [2e5]. The risk of
different clinical expression of H. pylori-infection is thought to rely
on interactions between the host genetic factors and bacterial
factors. For instance, polymorphisms of pro-inﬂammatory cytokine
genes such as IL-8, IL-10, IL-17, IL-1b and TNF-a that enhance in-
ﬂammatory response of gastric mucosa, have been correlated to an
increased risk of gastric cancer and peptic ulcer [6e11]. It has been
shown that the mucosal levels of several cytokines are signiﬁcantly
higher in H. pylori-infected with virulence factors groups in com-
parison to H. pylori-infected without virulence factors groups [12e
14]. Even though mucosal H. pylori colonization induces vigorous
immune responses involving both the innate and adaptive immune
system, the infection is not removed, and a state of chronic active
Table 1
PCR primers for ampliﬁcation of virulence factors.
Primer
designation
Primer sequence Size of PCR
product (bp)
References
vacA m1/
m2
vacAmF: 50-CAATCTGTCCAATCAA
GCGAG-30
567 bp (m1) [33]
vacAmR: 50-GCGTCTAAATAATTCC
AAGG-30
642 bp (m2)
vacA s1/
s2
VA1-F: 50-ATGGAAATACAACAAA
CACAC-30
259 bp (s1) [34]
VA1-R: 50-CTGCTTGAATGCGCCAAAC-30 286 bp (s2)
oipA oipA-F:CAAGCGCTTAACAGATAGGC-3 430 bp [35]
oipA-R:AAGGCGTTTTCTGCTGAAG-3
iceA1 iceA1F- 5-GTGTTTTTAACCAAAGTATC-3 247 bp [36]
iceA1R-5-CTATAGCCASTYTCTTTGCA-3
iceA2 iceA2F: 5-GTTGGGTATATCACAAT
TTAT-3
229 or
334 bp
[36]
iceA2R: 5-TTRCCCTATTTTCTAGTA
GGT-3
babA2 bab7-F: 50-CCAAACGAAACAAAAA
GCGT-3
271 bp [37]
bab7-R: 50-GCTTGTGTAAAAGCCG
TCGT-3
cagA cag1: 5-ATGACTAACGAAACTATT
GATC-3
232 bp [38]
cag2 5-CAGGATTTTTGATCGCTTTATT-3
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T cells are generally hyporesponsive and infected gastric tissues
have also shown the presence of transforming growth factor b
(TGF-b), which has a suppressive effect on T cells [16e18]. Recent
studies have demonstrated that CD4þ CD25þ regulatory T cells
(Tregs) suppress the immune response against H. pylori [19e21].
Mouse model studies have shown that in vivo depletion of Tregs in
infected mice leads to increased gastric inﬂammation and reduced
colonization of H. pylori [20]. The dysfunction or depletion of Treg
cells is associated with autoimmune diseases, allergy and inﬂam-
matory bowel disease [22]. Today, it is established that regulatory T
cells include two distinct subsets, the naturally occurring FOXP3-
expressing CD4þCD25high Treg cells, Tr1 cells secreting interleukin
IL-10, and Th3 cells characterized by transforming growth factor
(TGF-b1) secretion [23]. Among the FOXP3þCD4þCD25high Treg
cells, two distinct subsets can be distinguished: (a) thymus derived
naturally occurring FOXP3þCD4þCD25high Treg cells and (b)
peripherally induced FOXP3þCD4þCD25high Treg cells. For the dif-
ferentiation of the latter subset, TGF-b1 has been reported to play
an important regulatory role by induction of FOXP3 gene expres-
sion in naive CD4þ T cells at the site of inﬂammation [24]. In animal
models, the functional role of Treg cells in the context of H. pylori-
infection has been investigated, recently. During interaction with
H. pylori, FOXP3 expressing Treg cells suppressed the immune
response toward the bacterium [25]. Gastric Treg cells were able to
actively suppress H. pylori-induced T-cell proliferation and INF-g
production [19]. Moreover, H. pylori-infection is an established risk
factor for gastric cancer. In fact, the population of Tregs in tumor-
inﬁltrating lymphocytes is signiﬁcantly larger than in normal tis-
sue in several malignancies, including gastric cancer [19,26e29].
These ﬁndings suggest that Tregs contribute to the persistence of
H. pylori-infection, which may be closely related to gastric carci-
nogenesis. Regulatory T cells are thought to be a functionally
unique subset of CD4þ T cell populations and function to maintain
immune homeostasis [30,31]. The aim of this study was to inves-
tigate the expression of TGF-b1 in the context of H. pylori coloni-
zation in chronic gastritis, to examine the relationship between it
and histopathologic ﬁndings and to compare it with virulence
factors.
2. Materials and methods
2.1. Patients and sampling
In this retrospective study a total of 86 subjects, undergoing
endoscopy at Hajar University Hospital, were included (Table 1).
The study was approved by the human research ethics committee
at Shahrekord University and informed consent was obtained from
each volunteer before participation. The groups were characterized
as follows: the H. pyloriepositive group (n ¼ 48: 16 males, 32 fe-
males; mean age: 42.4  14.82 years); the H. pylorienegative group
(n ¼ 38: 18 males, 20 females; mean age: 38.18  16.51 years).
H. pylori-infection was determined by the rapid urease test, PCR
(16srRNA, glmM) and histological examination of biopsies taken
from the corpus. Patients were classiﬁed as H. pylori-infected only if
the four tests were positive, respectively. Four biopsies were
collected from 86 H. pylori-infected, and used for rapid urease test,
histological examination, assessment of bacterial virulence factors,
detection of H. pylori and cytokine RNA analysis.
2.2. Histological examination
Sections of biopsy specimens were embedded in 10% buffered
formalin and stained with hematoxylin and eosin to examine
gastritis and with giemsa to detect H. pylori. The histologicalseverity of gastritis was blindly graded from normal to severe based
on the degree of mononuclear cell (MNC) and polymorphonuclear
leukocyte (PMN) inﬁltration, and atrophy according to the Updated
Sydney system [32] on a four-point scale: 0, no; 1, mild; 2, mod-
erate; and 3, severe changes.
2.3. PCR ampliﬁcation
DNA for polymerase chain reaction (PCR) was extracted using the
biospin tissue genomic DNA extraction kit (BioFlux, Japan). Speciﬁc
primers for PCR ampliﬁcation of different genes are shown in Table 1.
For vacA, cagA, iceA1, iceA2 and babA2 evaluation, the PCR program
comprised 35 cycles of denaturation (at 94 C for 30 s), annealing (at
56 C for 30 s, extension at 72 C for 30 s), and one ﬁnal extension (at
72 C for 5min). ForoipA, ampliﬁcationwasperformedwith 35 cycles
of denaturation (at 94 C for30 s, annealing at 60 C for 30 s, extension
at 72 C for 30 s), and one ﬁnal extension (at 72 C for 5 min).
2.4. Quantitative analysis for TGF-b1 mRNA in the gastric mucosa
using real-time PCR
Total RNA was isolated from whole gastric biopsy specimens
using total RNA extraction biozol (bioﬂux, Japan). An aliquot con-
taining 0.2 mg of total RNA was used for the reverse transcription
reaction, which was conducted using the superscript ﬁrst-strand
cDNA synthesis system (Fermentas, Finland), according to the
manufacturer’s instructions. The sequences of oligonucleotide
primer and probe are shown in Table 2. The quantiﬁcation of TGF-b1
mRNA levels was performed using a Rotor-Gene 3000 (Corbett,
Australia). Real-timePCRreactionswereperformed ina total volume
of 25 ml containing 3 ml of synthesized cDNA solution, 12.5 ml of 2
Rotor-Gene Probe PCR Master Mix (Qiagen, Germany), 500 nM of
each primer and 250 nM of the TaqMan probe. Ampliﬁcation pro-
gram included a pre-warming step (10 min at 94 C), denaturation
step (94 C for 15 s) and an annealing/extension step (60 C for 60 s).
The expression levels of cytokinemRNAwere expressed as the ratio
of cytokinemRNA to b-actinmRNA (cytokinemRNA/b-actinmRNA).
Each assay was performed in duplicate and each cytokine assay was
performed testing all RNA samples in the same experiment. Relative
quantiﬁcationof cytokine tob-actin (cytokinemRNA/b-actinmRNA)
was determined using2DCt ¼ 2(Ct, TGF-b1Ct, b-actin) method [39].
Table 4
Frequency of virulence factors in H. pylori positive biopsies.
Genotype Number (%)
oipA iceA1 iceA2 babA
þ þ þ þ 5 (10.4)
þ þ  þ 20 (41.1)
þ þ   4 (8.3)
þ  þ þ 14 (29.1)
þ  þ  1 (2)
þ   þ 2 (4.1)
þ    1 (2)
    1 (2)
48 (100%)
Table 2
Primer and probe sequences employed in this study.
Gene Primer and probe sequence
b-actin Forward 5-AGCCTCGCCTTTGCCGA-3
Reverse 5-CTGGTGCCTGGGGCG-3
Probe FAM-CCGCCGCCCGTCCACACCCGCC-TAMRA
TGF-b1 Forward 5-CAGCAACAATTCCTGGCGATA-3
Reverse 5-AAGGCGAAAGCCCTCAATTT-3
Probe FAM-CTGCTGGCACCCAGCGACTCG-TAMRA
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Data were analyzed using GraphPad Prism 5 Demo (GraphPad
Software, San Diego, California, USA). Data are expressed as raw and
mean if not stated otherwise. Age was analyzed by unpaired Stu-
dent’s T-Test. Normality test was used to determine whether a data
set was well-modeled by a normal distribution or not. Cytokine
expression was presented as mean and differences between
infected and uninfected groups were analyzed using the Student’s
T-Test. Also for gene expression values between H. pylori-infected
patients and virulence factors, the parametric Student’s T-Test and
for comparison of more than two groups, one-way ANOVA test
were used. Categorical data (between virulence factors) are pre-
sented as frequencies; comparisons were made using the Chi-
square or Fisher exact test if <5 samples were in one group. P
values <0.05 were considered to be statistically signiﬁcant.
3. Results
3.1. Genotype
Table 3 gives an overview of the frequency distribution of the
vacA s andm alleles and the cagA status. The vacA s1 andm2 alleles
as well as cagA were predominant. Mixed vacA s1/s2 genotypes
were found in six patients (12.5%) and mixed vacA m1/m2 geno-
types were found in four patients (8.3%). The oipA, babA2, iceA1
and iceA2 genes respectively were found in 97.9%, 85.4%, 60.4% and
41.7% of the H. pylori positive biopsies (Table 4).
3.2. Correlation of vacA alleles and presence of virulence factors
The cagA gene was detected in 60.4% (29 biopseis) of H. pylori
positive specimens. The association between vacA alelles and
presence of virulence factors is described in Table 5. Of the 29
H. pylori positive specimens that were positive for cagA, 26 wereTable 3
Frequency distribution of the vacA allele variants s and m and the cagA status for
the total of study patients analyzed.
Genotype Total
N %
vacA s-region
s1 34 70.8
s2 8 16.7
s1 and s2a 6 12.5
vacA m-region
m1 13 27.1
m2 31 64.6
m1 and m2a 4 8.3
cagA
Positive 29 60.4
Negative 19 39.6
Total 48 100%
a The mixed genotypes of virulence factors were excluded in quantitative
analysis.associated with the toxin-producing vacA s1 and only 2 cagA-
positive were vacA s2 and 16 of them were associated with the
toxin-producing vacA s1m2 and only 7 were vacA s1m1 and 2
strains were vacA s2m2.
3.3. TGF-b1 expression is enhanced in H. pylori-infected gastric
mucosa
TGF-b1 mRNA level was detectable in all samples regardless of
whether biopsies were taken from H. pylori-infected or uninfected
patients. TGF-b1 expression was signiﬁcantly more in biopsy
specimens of H. pylori-infected patients compared with uninfected
patients (p ¼ 0.04) (Fig. 1). If the mean H. pylori-positive group is
0.0041 and the mean H. pylori-negative group is 0.0004 then the
difference in the TGF-b1 mRNA expression in the H. pylori-positive
compared with the H. pylori-negative patients is 0.0041/0.0004 or
8.9-fold.
3.4. Effect of vacA allele variants in H. pylori-infected on the
mucosal TGF-b1 mRNA level in gastric mucosa
The results showed that in H. pylori-infected patients; mucosal
TGF-b1 mRNA level was dependent on the vacA status. The differ-
ence in the TGF-b1 mRNA expression in the vacA s1-positive
H. pylori strains compared with the vacA s2-positive H. pylori
strains is 0.0045/0.0004 or 10.85-fold. Mucosal TGF-b1 mRNA
expression in gastritis patients with vacA m1-positive was not
signiﬁcantly higher than those observed in gastritis patients with
vacA m2-positive (0.0081/0.0017 or 4.64-fold). Mucosal TGF-b1
mRNA expression in gastritis patients with vacA s1m1-positive was
also signiﬁcantly higher than those observed in gastritis patients
with vacA s1m2-positive (0.0081/0.0026 or 3.11-fold) and vacA
s2m2-positive (0.0081/0.0004 or 20.25-fold) (Fig. 2).
3.5. Effect of others virulence factors in H. pylori-infected on the
mucosal TGF-b1 mRNA level in gastric mucosa
A mucosal TGF-b1 mRNA level was independent of virulence
factors status. If the mean H. pylori-positive group is 0.005 and the
mean H. pylori-negative group is 0.007 then the difference in the
TGF-b1 mRNA expression in the cagA-positive H. pylori strains
compared with the cagA-negative H. pylori strains is 0.005/0.0007
or 6.9-fold, the difference in the TGF-b1 mRNA expression in the
babA2-positive H. pylori strains compared with the babA2-negative
H. pylori strains is 0.0038/0.0008 or 4.47-fold, the difference in the
TGF-b1 mRNA expression in the iceA1-positive H. pylori strains
compared with the iceA1-negative HP strains is 0.0052/0.0007 or
6.62-fold and the difference in the TGF-b1 mRNA expression in the
iceA2-positive H. pylori strains compared with the iceA2-negative
H. pylori strains is 0.0013/0.0048 or 0.27-fold (Fig. 3).
Table 5
Correlation of vacA alleles with the cagA, babA2, iceA1 and iceA2 genotype of the samples studied.
vacA genotype cagA babA2 iceA1 iceA2
Positive Negative Positive Negative Positive Negative Positive Negative
s1m1 7 4 10 1 6 5 4 7
s1m2 16 6 16 6 14 8 8 14
s2m2 2 6 7 1 3 5 4 7
P value 0.06 0.993 0.391 0.524
s1 26 11 30 7 24 13 12 25
s2 2 6 7 1 3 5 4 4
P value 0.018 0.67 0.157 0.352
m1 7 4 10 1 6 5 4 7
m2 22 14 29 7 21 15 15 21
P value 0.881 0.429 0.826 0.756
Fig. 1. Relative expression level of TGF-b1 mRNA in gastric mucosa shown by H. pylori
status. RNA was extracted from gastric biopsies of 48 H. pylori-infected patients, 38
H. pylori-uninfected patients and analyzed for TGF-b1 by real-time PCR. Levels are
normalized to b-actin. P values <0.05 was considered statistically signiﬁcant using the
Student’s T-Test.
Fig. 2. Relative expression level of TGF-b1 mRNA in H. pylori-infected patients shown by
patients (vacA s1 ¼ 34 and s2 ¼ 8 patients) (vacA m1 ¼ 13 and m2 ¼ 31 patients) (vacA s1
G. Rahimian et al. / Microbial Pathogenesis 67-68 (2014) 1e743.6. Correlation between mucosal TGF-b1 mRNA levels and grade of
chronic inﬂammation
The degree of chronic inﬂammationwas assessed and graded as
follows: 31.25% [15] mild, 45.83% [22] moderate and 22.9% [11]
severe in the studied population. Fig. 4 shows the relationship
between the mucosal TGF-b1 mRNA expression and chronic
inﬂammation (mononuclear cell inﬁltration) scores. There was a
signiﬁcant correlation between the mucosal TGF-b1 mRNA
expression and the chronic inﬂammation scores (p ¼ 0.006).
4. Discussion
Most H. pylori infections begin in childhood and persist lifelong
in the host without speciﬁc treatment. Although H. pylori induce a
strong gastric inﬂammation, the pathogens are not cleared, and
chronic or persistent inﬂammation is generally established. The
exact mechanisms by which H. pylori escapes the bactericidal ef-
fects of gastric acid or how it colonizes the gastric mucosa and
damages the gastric epithelial cells by H. pylori are not well un-
derstood. H. pylori induced gastric mucosal damage has been8.
6.
4.
2.
vacA allelic variants. RNA was extracted from gastric biopsies of 48 H. pylori-infected
m1 ¼ 12, s1m2 ¼ 18 and s2m2 ¼ 8 patients).
8.
6.
4.
2.
4.
6.
2.
1.
8.
6.
4.
2.
8.
6.
4.
2.
Fig. 3. Mucosal TGF-b1 mRNA expression in gastritis patients and virulence factors. RNA was extracted from gastric biopsies of 48H. pylori-infected patients. Levels are normalized
to b-actin. P values <0.05 was considered statistically signiﬁcant using the Student’s T-Test.
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bacterial cytotoxic factors. The H. pylori vacuolating cytotoxin
(vacA) recently has been shown to contribute to persistent infec-
tion by inhibiting the proliferation and immune response of T cells
[40,41]. Unlike acquired immune system, other investigators [42]
have reported that vacA may be a driving factor in efﬁcient non-
speciﬁc immune system. The role of vacA in H. pylori infected
gastric mucosa remains unclear but our results indicate that in
H. pylori-infected patients; mucosal TGF-b1 mRNA level is depen-
dent on the vacA status. The results indicate that vacA s1 and s1m1
are associated with increased mucosal TGF-b1 mRNA level. Envi-
ronmental factors, host genetics, considerable genetic diversity andFig. 4. Relative expression level of TGF-b1 mRNA in H. pylori-infected patients shown
by grade of gastritis.pathogenicity between different H. pylori strains may contribute to
various clinical outcomes [43]. Recent numerous studies have
shown that H. pylori-induced chronic inﬂammation could be
associated not with a bacterial virulent factor but rather with the
host’s immunologic tolerance. Treg cells can suppress the prolif-
eration and activation of antigen-speciﬁc T cells and they are
described as the key regulator of the immune system in the
maintenance of immunologic tolerance. Recently, the close corre-
lation between H. pylori-infection and immunosuppressive Treg
cells in animal and human models has been reported. It has been
demonstrated that the depletion of Treg cells in H. pylori-infected
mice causes an impressive increase in gastric inﬂammation and a
reduction in bacterial colonization [20]. This study has shown that
Treg cells suppress Th1-mediated immune response induced by
H. pylori to contribute to the bacteria’s persistent colonization in
the gastric mucosa and therefore may play a major role in inducing
chronic gastritis. An in vitro study found that CD4þ memory T cells
from the peripheral blood in H. pylori-infected patients were less
responsive to H. pylori antigens than were cells in H. pylori-unin-
fected, whereas depletion of FOXP3þTreg cells increased the
responsiveness of CD4þ memory T cells [44]. This study indicated
that FOXP3þTreg cells suppress CD4þ memory T-cell responses to
H. pylori in infected patients and reduce induction of T cell-
mediated mucosal damage and T cell mediated protection against
bacterial colonization. Study by Lundgren and colleagues indicated
that frequency of CD4þCD25high Treg cells in gastric mucosa
H. pylori-infected adults increased, compared to uninfected, using
immunohistochemistry [25]. This was the in vitro study to examine
the suppressive function of Treg cells in gastric mucosa of H. pylori-
infected adults. Harris and colleagues evaluated the gastric histo-
pathology and Treg cells in H. pylori-infected adults and children
[45]. In spite of similarH. pylori densities, the intensity of gastritis in
children was noticeably less than that in adults. Treg numbers and
immune suppressive cytokine, IL-10, TGF-b1, weremarkedly higher
in the mucosal of H. pylori-infected children compared to infected
G. Rahimian et al. / Microbial Pathogenesis 67-68 (2014) 1e76adults. This results show that inH. pylori-infected children, Treg cell
responses downregulate the gastric mucosal inﬂammation. Asso-
ciations between the maintenance, development, and induction of
Treg cells and TGF-b1 have been studied. Chen and colleagues
demonstrated that TGF-b1 induced FOXP3 gene expression in naive
CD4þT cells at the mucosal of H. pylori-infected patients, which was
essential for the differentiation of CD4þCD25highFOXP3þTreg cells
in peripheral blood [46]. These ﬁndings introduce FOXP3þTreg cells
as a major source of TGF-b1 in H. pylori gastritis. Sher and Kullberg
indicated that Treg cells down regulate Helicobacter hepaticus-
induced colonic inﬂammation in a mouse model of inﬂammatory
bowel disease through the release of TGF-b1 [47]. Both studies
showed that the immunosuppressive activity of TGF-b1 was asso-
ciated with Treg cells. However, the associations between Treg cells
and TGF-b1 in H. pylori-infection have not yet been comprehen-
sively studied. In the gut of healthy adults, TGF-b1 is an important
negative regulator of the Th1 type immune response [48]. TGF-b1
has been reported to be over expressed in the antral of H. pylori-
infected adults [17]. The results of our study show that H. pylori-
infection is associated with increased expression of TGF-b1 in
children and that FOXP3þTreg cells correlate positively with TGF-b1
expression. Our ﬁndings also show that the mucosal TGF-b1 mRNA
level is increased in the H. pylori-infected patients compared with
uninfected patients and is correlated positively with vacA, types of
disease, and grade of chronic inﬂammation in patients infected
with H. pylori. The results indicate that vacA secreted by H. pylori
may induce the mucosal TGF-b1 mRNA which contributes to
persistent infection by inhibiting the proliferation and immune
response of T cells. Understanding how H. pylori induces Treg cells
in patients infected and how Th1 cells appear to ﬁnally override the
Treg cell inﬂuence on H. pylori-induced inﬂammation in adults
warrant critical investigation.
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